DSG-Ⅰ型生物信息肝病治疗仪对肝炎肝硬化的影响

Clinical Research on Liver Cirrbosis Induced by Hepatitis Treated by Medical Instrument on Hepatic Diseases of Type I DSG

目的:观察DSGⅠ型生物信息肝病治疗仪治疗肝炎肝硬化的疗效。方法:选择肝炎肝硬化患者180例,随机分为两组,对照组以西药常规治疗,治疗组在常规治疗的基础上加用DSGⅠ型生物信息肝病治疗仪照射肝区,观察治疗后的总有效率、肝功能、门静脉主干内径及血流量、血流速度和肝纤维化指标HA、LN、PCⅢ、ⅣC的变化。结果:经治疗后治疗组总有效率优于对照组(P<0.05),患者ALT、TBil明显降低,A和A/G升高,肝纤维化指标显著降低,同时B超显示门静脉内径变窄、血流量增多、血流速度变快,与对照组比较,有显著性或非常显著性差异(P<0.05或0.01)。结论:DSGⅠ型生物信息肝病治疗仪治疗肝炎肝硬化疗效显著,能明显改善肝功能,降低肝纤维化指标及门静脉压力,具有保肝降酶和抗肝纤维化作用。

Objective： To study the therapeutic efficacy of the medical instrument on hepatic diseases of type Ⅰ DSG.Methods： 180 cases with liver cirrhosis induced by hepatitis were randomly divided into two groups： the control group were treated by western medicine together with some routine treatment, while the treatment group were treated as the control group plus medical instrument on hepatic diseases of type Ⅰ DSG by which the hypochondrium was irradiated. Such marks as the total efficacy, liver funcititon, the inner diameter of portal vein, the volume of blood flow and the velocity of blood flow of portal vein, some marks related to fibrosis, ie, HA, LN, PC-Ⅲ, Ⅳ-C were observed.Results： After treatment the total efficacy rate of the therapeutic group was significantly higher than that of the control group （ P 〈 0.05） ; ALT, TBil of the patients were markedly reduced, A and A/G were lifted and some marks related to fibrosis were significantly reduced; meanwhile, the inner diameter of the portal vein was widened, its blood flow was increased and its velocity of blood flow was faster （P〈0.05 or 0.01） .Conclusion： Medical instrument on hepatic diseases of type Ⅰ DSG is effeeitve in treating liver cirrhosis induced by hepatitis. It can improve the liver function, reduce the marks related to fibrosis and the pressure of portal vein.